Treatment and risk factors for recurrence after curative resection of gastrointestinal stromal tumors of the stomach

World Journal of Surgery

Volumn 28, Issue 9, 2004, Pages 870-875

  Mochizuki, Yoshinari ^a   Kodera, Yasuhiro ^b   Ito, Seiji ^a   Yamamura, Yoshitaka ^a   Kanemitsu, Yukihide ^a   Shimizu, Yasuhiro ^a   Hirai, Takashi ^a   Yasui, Kenzo ^a   Inada, Ken Ichi ^a   Kato, Tomoyuki ^a  

^a AICHI CANCER CENTER HOSPITAL   (Japan)

^b NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CANCER RECURRENCE; CANCER SURGERY; CELL PROLIFERATION; DATA BASE; DISEASE COURSE; EVALUATION; FEMALE; FOLLOW UP; GASTROINTESTINAL STROMAL TUMOR; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; PROTEIN EXPRESSION; RECURRENT DISEASE; REGISTER; RELAPSE; RISK ASSESSMENT; RISK FACTOR; STOMACH CANCER; TUMOR VOLUME;

ADULT; AGED; AGED, 80 AND OVER; FEMALE; GASTROINTESTINAL STROMAL TUMORS; HUMANS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; RETROSPECTIVE STUDIES; RISK FACTORS; STOMACH NEOPLASMS;

EID: 6344285216     PISSN: 03642313     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00268-004-7418-0     Document Type: Article

References (34)

1. McGrath PC, Neifeld JP, Lawrence W, et al. Gastrointestinal sarcomas. Analysis of prognostic factors. Ann. Surg. 1987;206:706-710
2. Ng EH, Pollock RE, Munsell MF, et al. Prognostic factors influencing survival in gastrointestinal leiomyosarcomas. Implications for surgical management and staging. Ann. Surg. 1992;215:68-77
3. Suster S. Gastrointestinal stromal tumors. Semin. Diagn. Pathol. 1996; 13:297-313
4. Kindblom LG, Remotti HE, Aldenborg F, et al. Gastrointestinal pacemaker cell tumor (GIPACT): gastrointestinal stromal tumors show phenotypic characteristics of the interstitial cells of Cajal. Am. J. Pathol. 1998;152:1259-1269
5. Evans HL. Smooth muscle tumors of the gastrointestinal tract. A study of 56 cases followed for a minimum of 10 years. Cancer 1985;56:2242-2250
6. Fujimoto Y, Nakanishi Y, Yoshimura K, et al. Clinicopathologic study of primary malignant gastrointestinal stromal tumor of the stomach, with special reference to prognostic factors: analysis of results in 140 surgically resected patients. Gastric Cancer 2003;6:39-48
7. Miettinen M, El-Rifai W, Sobin L, et al. Evaluation of malignancy and prognosis of gastrointestinal stromal tumors: a review. Hum. Pathol. 2002;33:478-483
8. Pidhorecky I, Cheney RT, Kraybill WG, et al. Gastrointestinal stromal tumors: current diagnosis, biologic behavior, and management. Ann. Surg. Oncol. 2000;7:705-712
9. Koga H, Ochiai A, Nakanishi Y, et al. Reevaluation of factors in gastric leiomyosarcoma. Am. J. Gastroenterol. 1995;90:1307-1312
10. Pierie JP, Choudry U, Muzikansky A, et al. The effect of surgery and grade on outcome of gastrointestinal stromal tumors. Arch. Surg. 2001; 136:383-389
11. DeMatteo RP, Lewis JJ, Leung D, et al. Two hundred gastrointestinal stromal tumors: recurrence patterns and prognostic factors for survival. Ann. Surg. 2000;231:51-58
12. Kwon SJ. Surgery and prognostic factors for gastric stromal tumor. World J. Surg. 2001;25:290-295
13. Skandalakis JE, Gray SW, Shepard D, et al. Smooth muscle tumors of the alimentary tract. Springfield, IL, Charles C Thomas, 1960;79-80
14. Remine WH. Gastric sarcomas. Am. J. Surg. 1970;120:320-323
15. Bandoh T, Isoyama T, Toyoshima H. Submucosal tumors of the stomach: a study of 100 operative cases. Surgery 1993;113:498-506
16. Carson W, Karakousis C, Douglass H, et al. Results of aggressive treatment of gastric sarcoma. Ann. Surg. Oncol. 1994;1:244-251
17. Shiu MH, Farr GH, Papachristou DN, et al. Myosarcomas of the stomach: natural history, prognostic factors and management. Cancer 1982; 49:177-187
18. Lindsay PC, Ordonez N, Raaf JH. Gastric leiomyosarcoma: clinical and pathological review of fifty patients. J. Surg. Oncol. 1981;18:399-421
19. Chen H, Pruitt A, Nicol TL, et al. Complete hepatic resection of metastases from leiomyosarcoma prolongs survival. J. Gastrointest. Surg. 1998;2:151-155
20. DeMatteo RP, Shah A, Fong Y, et al. Results of hepatic resection for sarcoma metastatic to liver. Ann. Surg. 2001;234:540-547
21. Kodera Y, Ito S, Yamamura Y, et al. Clinical relevance of follow-up after curative surgery for gastric carcinoma. Ann. Surg. Oncol. 2003;10: 898-902
22. Roy M, Sommers SC. Metastatic potential of gastric leiomyosarcoma. Pathol. Res. Pract. 1989;185:874-877
23. Baak JPA. Mitosis counting in tumors. Hum. Pathol. 1990;21:683-685
24. Demarchi LM, Reis MM, Palomino SA, et al. Prognostic values of stromal proportion and PCNA, Ki-67, and p53 proteins in patients with resected adenocarcinoma of the lung. Mod. Pathol. 2000;13:511-520
25. Kikuyama S, Kubota T, Shimizu K, et al. Ki-67 antigen expression in relation to clinicopathological variables and prognosis in gastric cancer. Oncol. Rep. 1998;5:867-870
26. Trihia H, Murray S, Price K, et al. Ki-67 expression in breast carcinoma: its association with grading systems, clinical parameters, and other prognostic factors - a surrogate marker? Cancer 2003;97:1321-1331
27. Ma CK, De Peralta MN, Amin MB, et al. Small intestinal stromal tumors: a clinicopathologic study of 20 cases with immunohistochemical assessment of cell differentiation and the prognostic role of proliferation antigens. Am. J. Clin. Pathol. 1997;108:641-651
28. Goldblum JR, Appelman HD. Stromal tumors of the duodenum. A histologic and immunohistochemical study of 20 cases. Am. J. Surg. Pathol. 1995;19:71-80
29. Toquet C, Le Neel JC, Guillou L, et al. Elevated (> or = 10%) MIB-1 proliferative index correlates with poor outcome in gastric stromal tumor patients: a study of 35 cases. Dig. Dis. Sci. 2002;47:2247-2253
30. Hasegawa T, Matsuno Y, Shimoda T, et al. Gastrointestinal stromal tumor: consistent CD117 immunostaining for diagnosis, and prognostic classification based on tumor size and MIB-1 grade. Hum. Pathol. 2002; 33:669-676
31. Joensuu H, Roberts PJ, Sarlomo-Rikala M, et al. Effect of the tyrosine kinase inhibitor STI571 in a patient with metastatic gastrointestinal stromal tumor. N. Engl. J. Med. 2001;344:1052-1056
32. Wu PC, Langerman A, Ryan CW, et al. Surgical treatment of gastrointestinal stromal tumors in the imatinib (STI-571) era. Surgery 2003;13: 656-665
33. Demetri GD, von Mehren M, Blanke CD, et al. Efficacy and safety of imatinib mesylate in advanced gastrointestinal stromal tumors. N. Engl. J. Med. 2002;347:472-480
34. Nakanishi H, Mochizuki Y, Kodera Y, et al. Chemosensitivity of peritoneal micrometastases as evaluated using a green fluorescence protein (GFP) - tagged human gastric cancer cell line. Cancer Sci. 2003;94: 112-118